GoodRx Holdings, Inc. (GDRX)

NASDAQ

$2.70

-$0.12 (4.15%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$2.70$2.85

Open $2.84

52 Week Range

$2.61$5.81

Previous Close $2.82

Market Cap917.31M

Volume2.27M

Avg Volume3.68M

P/E (TTM)22.47

EPS (TTM)$0.12

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for GoodRx Holdings, Inc.

NOV172025

GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®

Source: Business Wire•28 days ago

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch of GoodRx for...

NOV42025

GoodRx Reports Third Quarter 2025 Results

Source: Business Wire•41 days ago

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the third quarter of 2025. Th...

OCT152025

GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment

Source: Business Wire•61 days ago

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription for hair loss treatment. Built for simplicity and transparency, GoodRx for Hair Lo...

OCT82025

GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call

Source: Business Wire•68 days ago

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its third quarter 2025 financial results after U.S. mark...

OCT62025

GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings

Source: Business Wire•70 days ago

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of Repatha® (evolocumab), a cholesterol-lowering therapy, at a significantly reduced cash price. S...

OCT12025

GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy

Source: Business Wire•75 days ago

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of its brand medication savings solution, RxSmartSaver powered by GoodRx, at Kroger pharmacies nat...